Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.005 Å; R factor = 0.066; wR factor = 0.160; data-to-parameter ratio = 15.7.
In the title compound, C 34 H 20 Cl 2 N 4 O 4 , the two quinazoline heterocyclic systems and the adjacent chlorobenzene rings are not coplanar, but oriented at dihedral angles of 66.66 (13) and 52.48 (12) , respectively. The quinazoline ring systems are nearly planar, with dihedral angles between the planes of the two rings of 5.43 (16) and 3.40 (14) , and are oriented at dihedral angles of 79.73 (13) and 83.52 (13) with respect to the adjacent benzene ring between them. Intermolecular C-HÁ Á ÁO hydrogen bonds contribute to the stability of the structure. In addition, weakstacking interactions [centroid-to-centroid distances = 3.872 (1) and 3.876 (1) Å ] are observed in the crystal structure.
Related literature
Many derivatives of quinazoline-4(3H)-one have been prepared, and their biological properties, such as antimicrobial, antidiabetic, anticonvulsant, antibacterial and antifungal activities, and their action as protein tyrosine kinase inhibitors, EGFR inhibitors and PDGFR phosphorylation inhibitors, have been studied by: Pandeya et al. (1999) ; Shiba et al. (1997) ; Malamas & Millen (1991) ; Mannschreck et al. (1984) ; Kung et al. (1999) ; Bartroli et al. (1998) ; Palmer et al. (1997) ; Tsou et al. (2001) ; Matsuno et al. (2002) . For the synthesis, see: Yang et al. (2008) . For related structures, see: Hu et al. (2006) ; Qu et al. (2008) ; Zeng et al. (2008) ; Sun et al. (2008) 
Data collection
Bruker SMART APEX CCD areadetector diffractometer Absorption correction: none 22711 measured reflections 6251 independent reflections 3432 reflections with I > 2(I) R int = 0.069 Refinement R[F 2 > 2(F 2 )] = 0.066 wR(F 2 ) = 0.160 S = 1.01 6251 reflections 397 parameters H-atom parameters constrained Á max = 0.23 e Å À3 Á min = À0.28 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) Àx þ 1 2 ; y À 1 2 ; Àz þ 1 2 .
Data collection: SMART (Bruker, 2000) ; cell refinement: SAINT (Bruker, 2000) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL. 
Comment
Quinazoline derivatives have broad biological properties. Some of these activities include antimicrobial (Pandeya et al., 1999; Shiba et al., 1997) , antidiabetic (Malamas & Millen, 1991) , anticonvulsant (Mannschreck et al., 1984) , antibacterial (Kung et al., 1999) , antifungal (Bartroli et al., 1998) , protein tyrosine kinase inhibitors (Palmer et al., 1997) , EGFR inhibitors (Tsou et al., 2001) and PDGFR phosphorylation inhibitors (Matsuno et al., 2002) . We have recently focused on the synthesis of heterocyclic compounds using an aza-Wittig reaction. We present here the synthesis and the crystal structure of the title compound, (I) ( Fig. 1) , which can be used as a precursor for obtaining bioactive molecules.
In the crystal structure of (I), the quinazoline heterocycle N1-C7/C8-C13/N2-C14 and N3-C22/C23-C28/N4-C21 and the adjacent chlorobenzene ring C1-C6 and C29-C34 are not co-planar, but oriented at the dihedral angles of 66.66 (13) and 52.48 (12)°, respectively. The nearly planar quinazoline ring system N1-C7/C8-C13/N2-C14 and N3-C22/ C23-C28/N4-C21 are oriented with respect to the adjacent ring C15-C20 at the dihedral angles of 79.73 (13) and 83.52 (13)°, respectively.
Significant intramolecular C-H···O hydrogen bonds contribute to the stability of the molecular configuration ( Fig. 2 and Table 1 ). The crystal structure (Fig. 2) is also stabilized by weak π-π (Table 1) stacking interactions with centroid-centroid separations of 3.872 (1) and 3.876 (1) Å for Cg2···Cg2 i and Cg2···Cg6 i , respectively, where Cg2 and Cg6 are the centroids of rings N3/C21-N4/C28-C27/C22 and C22-C27, respectively [symmetry code: (i) 1 -x, -y, 1 -z].
Experimental
To a solution of iminophosphorane (1.40 g, 3.0 mmol) in anhydrous THF (10 ml) was added 4-chlorophenyl isocyanate (3 mmol) under nitrogen at room temperature. After reaction, the mixture was allowed to stand for 10 h at 273-278 K, the solvent was removed under reduced pressure and diethyl ether/petroleum ether (1:2 v/v, 20 ml) was added to precipitate triphenylphosphine oxide. After filtration, the solvent was removed to give 1-(4-chlorophenyl)-3-(2-ethoxycarbonylphenyl) carbodiimide, which was used directly without further purification. To a solution of 1-(4-chlorophenyl)-3-(2-ethoxycarbonylphenyl) carbodiimide in THF (15 ml) was added m-dihydroxybenzene (0.18 g, 3 mmol). After the reaction mixture was allowed to stand for 0.5 h, the solvent was removed and anhydrous ethanol (10 ml) with several drops of EtONa in EtOH was added. The mixture was stirred for 2 h at room temperature. The solution was concentrated under reduced pressure and the residue was recrystallized from ethanol to give the title compound, (I). The product was recrystallized from methanol-dichloromethane (1:1 v/v, 20 ml) at room temperature to give crystals suitable for X-ray diffraction [m.p. 444 K, yield 45%].
Refinement
All H atoms were located in difference maps and treated as riding atoms with C-H = 0.93 Å, U iso = 1.2U eq (C) for Csp 2 . Fig. 1 . View of the molecular structure of (I), showing the atom labelling scheme and with displacement ellipsoids drawn at the 50% probability level. 
Figures
where P = ( Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating Rfactors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) C2-C1-C6 121.4 (3) C20-C19-O3 117.5 (2) C2-C1-Cl1 120.1 (3) C15-C20-C19 117.4 (2) C6-C1-Cl1 118.5 (3) C15-C20-H20 121.3 C1-C2-C3 119.0 (3) C19-C20-H20 121.3 C1-C2-H2 120.5 N3-C21-O3 121.6 (2) C3-C2-H2 120.5 N3-C21-N4 127.1 (2) C2-C3-C4 120.4 (3) O3-C21-N4 111.3 (2) C2-C3-H3 119.8 C23-C22-C27 118.6 (3) C4-C3-H3 119.8 C23-C22-N3 119.9 (3) supplementary materials sup-9
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